Your browser doesn't support javascript.
loading
Injectable Hydrogels Including Magnetic Nanosheets for Multidisciplinary Treatment of Hepatocellular Carcinoma via Magnetic Hyperthermia.
Gong, Jinyu; Hu, Jinlong; Yan, Xu; Xiang, Luyao; Chen, Sheng; Yang, Huai; Chen, Zichao; Hou, Qingbing; Song, Yonghong; Xu, Yunjun; Liu, Dongquan; Ji, Chaofei; Qin, Qin; Sun, Haiyi; Peng, Junbin; Cao, Baoqiang; Lu, Yang.
  • Gong J; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
  • Hu J; Department of General Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, P. R. China.
  • Yan X; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
  • Xiang L; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
  • Chen S; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
  • Yang H; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
  • Chen Z; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
  • Hou Q; Department of General Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, P. R. China.
  • Song Y; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
  • Xu Y; Department of Radiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, P. R. China.
  • Liu D; Department of General Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, P. R. China.
  • Ji C; Department of General Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, P. R. China.
  • Qin Q; Department of General Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, P. R. China.
  • Sun H; The First Clinical College, Anhui Medical University, Hefei, 230022, P. R. China.
  • Peng J; Department of General Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, P. R. China.
  • Cao B; Department of General Surgery, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, P. R. China.
  • Lu Y; Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, P. R. China.
Small ; 20(3): e2300733, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37452437
ABSTRACT
Relapse and unresectability have become the main obstacle for further improving hepatocellular carcinoma (HCC) treatment effect. Currently, single therapy for HCC in clinical practice is limited by postoperative recurrence, intraoperative blood loss and poor patient outcomes. Multidisciplinary therapy has been recognized as the key to improving the long-term survival rate for HCC. However, the clinical application of HCC synthetic therapy is restricted by single functional biomaterials. In this study, a magnetic nanocomposite hydrogel (CG-IM) with iron oxide nanoparticle-loaded mica nanosheets (Iron oxide nanoparticles@Mica, IM) is reported. This biocompatible magnetic hydrogel integrated high injectability, magnetocaloric property, mechanical robustness, wet adhesion, and hemostasis, leading to efficient HCC multidisciplinary therapies including postoperative tumor margin treatment and percutaneous locoregional ablation. After minimally invasive hepatectomy of HCC, the CG-IM hydrogel can facilely seal the bleeding hepatic margin, followed by magnetic hyperthermia ablation to effectively prevent recurrence. In addition, CG-IM hydrogel can inhibit unresectable HCC by magnetic hyperthermia through the percutaneous intervention under ultrasound guidance.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Silicatos de Aluminio / Hipertermia Inducida / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Silicatos de Aluminio / Hipertermia Inducida / Neoplasias Hepáticas Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article